
Salmeterol (50mcg) + Fluticasone Propionate (250mcg)
Active composition
+1 more active ingredient
Salmeterol activates β2-adrenergic receptors, leading to bronchodilation and improved airflow.
Fluticasone Propionate works by binding to glucocorticoid receptors, leading to the transcriptional regulation of anti-inflammatory proteins and inhibition of pro-inflammatory mediators, reducing airway inflammation.
Medical applications
Flutinorm-S 250 Inhacaps is a combination inhalation capsule containing Salmeterol (50mcg) and Fluticasone Propionate (250mcg), designed for the management of asthma and chronic obstructive pulmonary disease (COPD). Salmeterol is a long-acting beta2-adrenergic receptor agonist that helps relax the muscles in the airways, leading to bronchodilation and improved airflow. Fluticasone Propionate is a corticosteroid that reduces inflammation and swelling in the airways, thereby decreasing the frequency and severity of asthma attacks and exacerbations of COPD. The dual action of Flutinorm-S 250 Inhacaps provides both immediate relief of bronchospasm and long-term control of airway inflammation. This medication is typically prescribed for patients who require maintenance treatment to prevent symptoms such as wheezing, shortness of breath, and coughing. It is important to use Flutinorm-S 250 Inhacaps regularly as directed by a healthcare professional, even when symptoms are not present, to achieve optimal control of respiratory conditions. Patients should be advised on proper inhalation technique and informed about potential side effects, including oral thrush, hoarseness, and increased heart rate. Flutinorm-S 250 Inhacaps should not be used for acute asthma attacks and requires medical supervision during use.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Flutinorm-S 250 Inhacaps may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Flutinorm-S 250 Inhacaps during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Flutinorm-S 250 Inhacaps

Salmeterol (50mcg) + Fluticasone Propionate (250mcg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Salmeterol activates β2-adrenergic receptors, leading to bronchodilation and improved airflow.
Fluticasone Propionate works by binding to glucocorticoid receptors, leading to the transcriptional regulation of anti-inflammatory proteins and inhibition of pro-inflammatory mediators, reducing airway inflammation.
Medical applications
Flutinorm-S 250 Inhacaps is a combination inhalation capsule containing Salmeterol (50mcg) and Fluticasone Propionate (250mcg), designed for the management of asthma and chronic obstructive pulmonary disease (COPD). Salmeterol is a long-acting beta2-adrenergic receptor agonist that helps relax the muscles in the airways, leading to bronchodilation and improved airflow. Fluticasone Propionate is a corticosteroid that reduces inflammation and swelling in the airways, thereby decreasing the frequency and severity of asthma attacks and exacerbations of COPD. The dual action of Flutinorm-S 250 Inhacaps provides both immediate relief of bronchospasm and long-term control of airway inflammation. This medication is typically prescribed for patients who require maintenance treatment to prevent symptoms such as wheezing, shortness of breath, and coughing. It is important to use Flutinorm-S 250 Inhacaps regularly as directed by a healthcare professional, even when symptoms are not present, to achieve optimal control of respiratory conditions. Patients should be advised on proper inhalation technique and informed about potential side effects, including oral thrush, hoarseness, and increased heart rate. Flutinorm-S 250 Inhacaps should not be used for acute asthma attacks and requires medical supervision during use.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Flutinorm-S 250 Inhacaps may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Flutinorm-S 250 Inhacaps during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Flutinorm-S 250 Inhacaps















